Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049.HK) HKSE

2.10

-0.06(-2.78%)

Updated at October 17 04:08PM

Currency In HKD

Valuation

Market Cap726.14M
Enterprise Value562.69M
P/E Ratio5.9
PEG Ratio0.06
Price/Sales Ratio1.16
Price/Book Ratio0.62
Enterprise/Revenue0.72
Enterprise/EBITDA3.22

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.2
Operating Margin0.22

Management Effectiveness

Return On Assets0.07
Return On Equity0.11

Income Statement

Revenue881.16M
Revenue/Share1.65
Gross Profit685.25M
EBITDA236.33M
Net Income184.25M
Diluted EPS0.33

Balance Sheet

Total Cash748.3M
Total Cash/Share1.34
Total Debt72.4M
Total Debt/Equity0.04
Current Ratio1.52
Book Value Per Share3.09

Price History

52-Week Change45.83
52-Week High2.55
52-Week Low1.36
Moving Average 50 Days2.14
Moving Average 200 Days1.9

Statistics

Average Volume126,025
Shares Outstanding560.11M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.25
Trailing Annual Dividend Yield13
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A